Farallon Capital Management LLC Ptc Therapeutics, Inc. Transaction History

Farallon Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $4.29 Million - $6.12 Million	126,986 Added 21.16%	726,986 $24.6 Million
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $3.54 Million - $4.5 Million	-100,000 Reduced 14.29%	600,000 $27 Million
Q4 2018 Feb 14, 2019	BUY	$29.83 - $46.51 $8.35 Million - $13 Million	280,000 Added 66.67%	700,000 $24 Million
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $14.2 Million - $20.1 Million	420,000 New	420,000 $19.7 Million

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.